TrialJAMA network open2020

Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial.

Daniel V T Catenacci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.